JPRN-jRCT2080220845未知3 期
Phase III Clinical Study of Intravenous Administration of S-021812 in Pediatric Patients with Influenza Virus Infection
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Pediatric patient diagnosed as influenza virus infection
排除标准
- 未提供
研究者
相似试验
招募中
1 期
A Phase-I clinical study of intravenous AntiPlatelet, AntiCoagulant (APAC) in healthy subjects.CTRI/2023/04/051500Cadila Pharmaceutical Limited
尚未招募
1 期
Mesenchymal Stem Cell Therapy For Covid 19CTRI/2020/08/027043eurogen Brain and Spine Institute
进行中（未招募）
1 期
Trial to test the safety, half-life, and antiviral efficacy of a new drug (human antibody) called DZIF-10c (administered intravenously) in healthy volunteers and SARS-CoV-2-infected participantsSARS-CoV-2 infection (only mild to moderate disease)MedDRA version: 23.0Level: LLTClassification code 10084272Term: SARS-CoV-2 infectionSystem Organ Class: 100000004862EUCTR2020-003503-34-DEniversity of Cologne69
已完成
3 期
A Phase III Clinical Trial of Intra-arterial TheraSphere® in the Treatment of Patients with Unresectable Hepatocellular Carcinoma (HCC).liver cancer10019815hepatocellular carcinomaNL-OMON50334Biocompatibles UK Ltd.38
已完成
不适用
A randomised phase III study of intravenous (i.v.) zoledronate (administered for 12 versus 36 months) as an adjunct to standard therapies in the treatment of multiple myelomaMultiple myeloma and malignant plasma cell neoplasmsMultiple myelomaCancerISRCTN23172547Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (Netherlands)407